We report the case of a 4-year-old girl presenting with spinal and leptomeningeal dissemination following several subtotal resections of cerebellar pilocytic astrocytomas.

1.
Mamelak AN, Prados MD, Obana WG, et al: Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. J Neurosurg 1994;81:24–30.
2.
McCowage G, Tien R, McLendon R, et al: Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. Med Pediatr Oncol 1996;27:32–39.
3.
Rodriguez LA, Edwards MS, Levin VA: Management of hypothalamic gliomas in children: An analysis of 33 cases. Neurosurgery 1990;26:242–247.
4.
Braun-Fischer A, Romeike BF, Eymann R, et al: Pilocytic astrocytoma with subarachnoid dissemination. Radiologe 1997;37:899–904.
5.
Zimmerman RA: Pediatric supratentorial tumors. Semin Roentgenol 1990;25:225–248.
6.
Auer RN, Rice GP, Hinton GG, et al: Cerebellar astrocytoma with benign histology and malignant clinical course. Case report. J Neurosurg 1981;54:128–132.
7.
Bruggers CS, Friedman HS, Phillips PC, et al: Leptomeningeal dissemination of optic pathway gliomas in three children. Am J Ophthalmol 1991;111:719–723.
8.
Civitello LA, Packer RJ, Rorke LB, et al: Leptomeningeal dissemination of low-grade gliomas in childhood. Neurology 1988;38:562–566.
9.
Jamjoom AB, Jamjoom ZA, al-Rayess M: Intraventricular and leptomeningeal dissemination of a pilocytic cerebellar astrocytoma in a child with a ventriculoperitoneal shunt: Case report. Br J Neurosurg 1998;12:56–58.
10.
Mishima K, Nakamura M, Nakamura H, et al: Leptomeningeal dissemination of cerebellar pilocytic astrocytoma. Case report. J Neurosurg 1992;77:788–791.
11.
Morikawa M, Tamaki N, Kokunai T, et al: Cerebellar pilocytic astrocytoma with leptomeningeal dissemination: Case report. Surg Neurol 1997;48:49–51.
12.
Obana WG, Cogen PH, Davis RL, et al: Metastatic juvenile pilocytic astrocytoma. Case report. J Neurosurg 1991;75:972–975.
13.
Petronio J, Edwards MS, Prados M, et al: Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 1991;74:701–708.
14.
Tamura M, Zama A, Kurihara H, et al: Management of recurrent pilocytic astrocytoma with leptomeningeal dissemination in childhood. Childs Nerv Syst 1998;14:617–622.
15.
Versari P, Talamonti G, D’Aliberti G, et al: Leptomeningeal dissemination of juvenile pilocytic astrocytoma: Case report. Surg Neurol 1994;41:318–321.
16.
Buschmann U, Gers B, Hildebrandt G: Pilocytic astrocytomas with leptomeningeal dissemination: Biological behavior, clinical course, and therapeutical options. Childs Nerv Syst 2003;19:298–304.
17.
van der Wal EJ, Azzarelli B, Edwards-Brown M: Malignant transformation of a chiasmatic pilocytic astrocytoma in a patient with diencephalic syndrome. Pediatr Radiol 2003;33:207–210.
18.
Perilongo G, Garre ML, Giangaspero F: Low-grade gliomas and leptomeningeal dissemination: A poorly understood phenomenon. Childs Nerv Syst 2003;19:197–203.
19.
Figueiredo EG, Matushita H, Machado AG, et al: Leptomeningeal dissemination of pilocytic astrocytoma at diagnosis in childhood: Two cases report. Arq Neuropsiquiatr 2003;61:842–847.
20.
Endo H, Kumabe T, Jokura H, et al: Leptomeningeal dissemination of cerebellar malignant astrocytomas. J Neurooncol 2003;63:191–199.
21.
Akar Z, Tanriover N, Kafadar AM, et al: Chiasmatic low-grade glioma presenting with sacral intradural spinal metastasis. Childs Nerv Syst 2000;16:309–311.
22.
Pollack IF, Hurtt M, Pang D, et al: Dissemination of low grade intracranial astrocytomas in children. Cancer 1994;73:2869–2878.
23.
Kocks W, Kalff R, Reinhardt V, et al: Spinal metastasis of pilocytic astrocytoma of the chiasma opticum. Childs Nerv Syst 1989;5:118–120.
24.
Tihan T, Fisher PG, Kepner JL, et al: Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol 1999;58:1061–1068.
25.
Kepes JJ, Lewis RC, Vergara GG: Cerebellar astrocytoma invading the musculature and soft tissues of the neck. Case report. J Neurosurg 1980;52:414–418.
26.
Hoffman HJ, Humphreys RP, Drake JM, et al: Optic pathway/hypothalamic gliomas: A dilemma in management. Pediatr Neurosurg 1993;19:186–195.
27.
Miralbell R, Balart J, Matias-Guiu X, et al: Radiotherapy for supratentorial low-grade gliomas: Results and prognostic factors with special focus on tumour volume parameters. Radiother Oncol 1993;27:112–116.
28.
Castello MA, Schiavetti A, Padula A, et al: Does chemotherapy have a role in low-grade astrocytoma management? A report of 13 cases. Med Pediatr Oncol 1995;25:102–108.
29.
Massimino M, Spreafico F, Cefalo G, et al: High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 2002;20:4209–4216.
30.
Moghrabi A, Friedman HS, Burger PC, et al: Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. J Neurosurg 1993;79:223–227.
31.
Nishio S, Morioka T, Takeshita I, et al: Chemotherapy for progressive pilocytic astrocytomas in the chiasmo-hypothalamic regions. Clin Neurol Neurosurg 1995;97:300–306.
32.
Packer RJ, Sutton LN, Bilaniuk LT, et al: Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An update. Ann Neurol 1988;23:79–85.
33.
Prados MD, Edwards MS, Rabbitt J, et al: Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol 1997;32:235–241.
34.
Perilongo G, Gardiman M, Bisaglia L, et al: Spinal low-grade neoplasms with extensive leptomeningeal dissemination in children. Childs Nerv Syst 2002;18:505–512.
35.
Kleihues P, Cavenee WK: Pathology and Genetics of Tumors of the Nervous System. Lyon, IARC Press, 2000, p 47.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.